Who owns AEON?
Institutional ownership of AEON Biopharma Inc. from Form 13F, Q2 2026
22 institutional managers reported holding AEON Biopharma Inc. (AEON) in Form 13F filings for Q2 2026, with 12,802,787 shares worth $9.2M. The largest reported holder was Dauntless Investment Group, LLC. Managers that filed both quarters added a net 9,961,368 shares (+350.6%). 2 opened new positions and 4 sold out.
- Funds holding
- 22
- Value held
- $9.2M
- New / sold out
- 2 / 4
- Net shares, same filers
- +350.6%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of AEON
Share of 13F holdings is each fund's shares as a share of the 12,802,787 AEON shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Dauntless Investment Group, LLC Added+$7.2M
- StoneX Group Inc. New+$15K
- Geode Capital Management, LLC Added+$6K
- Citigroup Inc Added+$5K
- Tower Research Capital LLC (TRC) Added+$2K
- UBS Group AG Added+$633
- SBI Securities Co., Ltd. Added+$91
- Barclays PLC New+$42
Biggest sellers in Q2 2026
- XTX Topco Ltd Sold out-$20K
- Jane Street Group, LLC Sold out-$16K
- Vanguard Fiduciary Trust Co Trimmed-$711
- Vanguard Global Advisers, LLC Sold out-$100
- MAI Capital Management Sold out-$58
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $7.2M and sold $37K; 6 added and 1 trimmed.
Schedule 13D and 13G filings on AEON
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-17Ikarian Capital, LLC SCHEDULE 13G filed by AEON Biopharma Inc.Schedule 13G
- 2026-11-13Nantahala Capital Management, LLC SCHEDULE 13G filed by AEON Biopharma Inc.Schedule 13G
- 2026-08-21LYNCH TIMOTHY P SCHEDULE 13G filed by AEON Biopharma Inc.Schedule 13G
- 2026-07-21Stonepine Capital Management, LLC SCHEDULE 13G filed by AEON Biopharma Inc.Schedule 13G
- 2025-05-30Chernett Jorey SCHEDULE 13G filed by AEON Biopharma Inc.Schedule 13G
- 2025-01-22PALMISANO ROBERT J SCHEDULE 13D filed by AEON Biopharma Inc.Schedule 13D
- 2025-01-13L1 Capital Global Opportunities Master Fund, Ltd. SCHEDULE 13G filed by AEON Biopharma Inc.Schedule 13G
- 2025-01-08BIGGER CAPITAL FUND L P SCHEDULE 13G filed by AEON Biopharma Inc.Schedule 13G
Questions about AEON ownership
- Who owns AEON stock?
- 22 institutional investment managers reported AEON positions in their Form 13F filings for Q2 2026, holding 12,802,787 shares worth $9.2M in total. Dauntless Investment Group, LLC reported the largest position.
- Are funds buying or selling AEON?
- In Q2 2026, 2 managers opened new AEON positions, 6 added, 1 trimmed and 4 sold out. Managers that filed in both quarters added a net 9,961,368 shares.
- How current is this AEON institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to AEON by CUSIP. Options are left out. AEON news and filings · AEON insider trades · Top funds